Some more info [GxP / QC / QA]

posted by Ohlbe – France, 2021-09-17 22:28 (913 d 08:26 ago) – Posting: # 22587
Views: 5,638

Hi ElMaestro,

❝ One good question is what happens now. I would not be surprised if PanExcell and Synchron will cease to exist (might pop up under another name?), sponsors using the two CROs will be forced to abandon some/all of their MA's and/or repeat studies


Yes, indeed, in the USA: instructions to companies have now been posted on the FDA web site. Repeat all studies; therapeutic equivalence of already approved products is meanwhile changed to BX. Europe: it should not take them more than a year or two to decide what to do :sleeping:

❝ Have a look at the pdf files from FDA. Now answer this question: Which day were the letters issued?


❝ Do we really need to go looking for the date on the linking FDA page?


According to this new page: the letters were sent out on 15 September 2021.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
22,940 posts in 4,812 threads, 1,640 registered users;
32 visitors (0 registered, 32 guests [including 12 identified bots]).
Forum time: 05:54 CET (Europe/Vienna)

Those people who think they know everything
are a great annoyance to those of us who do.    Isaac Asimov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5